Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 250 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2422 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

25 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-CYCLOSPORINE 0.05% EMULSION Resolved 2023-11-16 2023-11-23 210431
TEVA-CYCLOSPORINE 0.05% EMULSION Resolved 2023-12-07 2024-03-21 212730
TEVA-CYCLOSPORINE 0.05% EMULSION Actual shortage 2024-05-16 2024-05-16 228149
TEVA-CLOXACILLIN 125MG GRANULES FOR SOLUTION Resolved 2017-08-21 2017-09-19 19937
TEVA-CLOXACILLIN 125MG GRANULES FOR SOLUTION Resolved 2021-01-07 2021-02-25 131063
TEVA-CLOXACILLIN 125MG GRANULES FOR SOLUTION Resolved 2023-06-08 2023-07-05 194054
TEVA-CLOXACILLIN 125MG GRANULES FOR SOLUTION Resolved 2023-06-19 2023-10-03 195518
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2019-10-03 2020-04-02 95408
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2019-10-03 2020-03-26 95411
NOVAMOXIN 50MG GRANULES FOR SUSPENSION Resolved 2020-02-07 2020-06-11 105596
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2020-04-10 2020-04-23 111841
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2020-05-14 2020-06-04 115196
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2022-05-19 2022-07-01 160983
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2022-08-18 2022-09-08 167159
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2022-09-22 2024-02-14 169966
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2022-10-20 2024-02-14 172263
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-02-02 2023-07-05 183361
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-06-16 2023-11-03 195109
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-06-16 2023-10-11 195112
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Resolved 2023-06-16 2023-10-11 195207

Showing 461 to 480 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353

Showing 21 to 40 of 250